Cite Filings / TLSI / 0001415889-24-029847

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

TriSalus Life Sciences, Inc. Filed 2024-12-19 Acc 0001415889-24-029847

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-05-02 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-19 4 CHIEF SCIENTIFIC & MANUFACT. sold 314 shares at $4.44 ($1,394)
2024-12-19 4 Director acquired 25,188 shares (grant or award)
2024-12-19 4 10% owner bought 62,972 shares at $3.97 ($249,999)
2024-12-19 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-19 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-12 4 Director sold 30,000 shares at $3.69 ($110,700)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…